<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30337479</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>45</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>06</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.</ArticleTitle><Pagination><StartPage>E10625</StartPage><EndPage>E10633</EndPage><MedlinePgn>E10625-E10633</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1808798115</ELocationID><Abstract><AbstractText>Israel experienced an outbreak of wild poliovirus type 1 (WPV1) in 2013-2014, detected through environmental surveillance of the sewage system. No cases of acute flaccid paralysis were reported, and the epidemic subsided after a bivalent oral polio vaccination (bOPV) campaign. As we approach global eradication, polio will increasingly be detected only through environmental surveillance. We developed a framework to convert quantitative polymerase chain reaction (qPCR) cycle threshold data into scaled WPV1 and OPV1 concentrations for inference within a deterministic, compartmental infectious disease transmission model. We used this approach to estimate the epidemic curve and transmission dynamics, as well as assess alternate vaccination scenarios. Our analysis estimates the outbreak peaked in late June, much earlier than previous estimates derived from analysis of stool samples, although the exact epidemic trajectory remains uncertain. We estimate the basic reproduction number was 1.62 (95% CI 1.04-2.02). Model estimates indicate that 59% (95% CI 9-77%) of susceptible individuals (primarily children under 10 years old) were infected with WPV1 over a little more than six months, mostly before the vaccination campaign onset, and that the vaccination campaign averted 10% (95% CI 1-24%) of WPV1 infections. As we approach global polio eradication, environmental monitoring with qPCR can be used as a highly sensitive method to enhance disease surveillance. Our analytic approach brings public health relevance to environmental data that, if systematically collected, can guide eradication efforts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brouwer</LastName><ForeName>Andrew F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-3779-5287</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eisenberg</LastName><ForeName>Joseph N S</ForeName><Initials>JNS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109; marisae@umich.edu jnse@umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pomeroy</LastName><ForeName>Connor D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shulman</LastName><ForeName>Lester M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hindiyeh</LastName><ForeName>Musa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manor</LastName><ForeName>Yossi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grotto</LastName><ForeName>Itamar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Public Health Services, Ministry of Health, Jerusalem 9101002, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koopman</LastName><ForeName>James S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eisenberg</LastName><ForeName>Marisa C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109; marisae@umich.edu jnse@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 GM110712</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM111274</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023321">Poliovirus Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023321" MajorTopicYN="N">Poliovirus Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">environmental surveillance</Keyword><Keyword MajorTopicYN="N">mathematical model</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">silent transmission</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30337479</ArticleId><ArticleId IdType="pmc">PMC6233100</ArticleId><ArticleId IdType="doi">10.1073/pnas.1808798115</ArticleId><ArticleId IdType="pii">1808798115</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720038</ArticleId><ArticleId IdType="pubmed">23798688</ArticleId></ArticleIdList></Reference><Reference><Citation>Routh J, Oberste S, Patel M. Poliomyelitis. In: Roush SW, Baldy LM, editors. Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention; Atlanta: 2017.</Citation></Reference><Reference><Citation>Nathanson N, Kew OM. From emergence to eradication: The epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172:1213&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991634</ArticleId><ArticleId IdType="pubmed">20978089</ArticleId></ArticleIdList></Reference><Reference><Citation>Anis E, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill. 2013;18:20586.</Citation><ArticleIdList><ArticleId IdType="pubmed">24084337</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L. Israel&#x2019;s silent polio epidemic breaks all the rules. Science. 2013;342:679&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">24202150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopel E, Kaliner E, Grotto I. Lessons from a public health emergency&#x2014;importation of wild poliovirus to Israel. New Engl J Med. 2014;371:981&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">25207764</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman LM, et al. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013. J Infect Dis. 2014;210:S304&#x2013;S314.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316849</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman LM, et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Euro Surveill. 2014;19:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24576471</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmueli DF, Khamaisi R. Bedouin communities in the Negev. J Am Plann Assoc. 2011;77:109&#x2013;125.</Citation></Reference><Reference><Citation>Yaari R, et al. Modeling the spread of polio in an IPV-vaccinated population: Lessons learned from the 2013 silent outbreak in southern Israel. BMC Med. 2016;14:95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918056</ArticleId><ArticleId IdType="pubmed">27334457</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt LR, Estivariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: A review of the epidemiology and estimation of the global burden. J Infect Dis. 2014;210:S380&#x2013;S389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10424844</ArticleId><ArticleId IdType="pubmed">25316859</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210:S283&#x2013;S293.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ. Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes. BMC Infect Dis. 2015;15:374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574397</ArticleId><ArticleId IdType="pubmed">26381878</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Kalkowska DA, Duintjer Tebbens RJ. Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses. Vaccine. 2015;33:1568&#x2013;1577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907970</ArticleId><ArticleId IdType="pubmed">25701673</ArticleId></ArticleIdList></Reference><Reference><Citation>Swirski S, Hasson Y. 2006. Invisible citizens: Israel government policy toward the Negev Bedouin (Adva Center, Tel Aviv)</Citation></Reference><Reference><Citation>Manor Y, et al. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013. Euro Surveill. 2014;19:20708.</Citation><ArticleIdList><ArticleId IdType="pubmed">24576473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick DR, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol. 2009;47:1939&#x2013;1941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2691077</ArticleId><ArticleId IdType="pubmed">19386844</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchenko Y, et al. Estimation of polio infection prevalence from environmental surveillance data. Sci Transl Med. 2017;9:eaaf6786.</Citation><ArticleIdList><ArticleId IdType="pubmed">28356510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis. 2015;211:1800&#x2013;1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887763</ArticleId><ArticleId IdType="pubmed">25505296</ArticleId></ArticleIdList></Reference><Reference><Citation>Applied Biosystems  2015 Real-time PCR: Understanding Ct, Technical Report. Available at  www3.appliedbiosystems.com/cms/groups/mcb_marketing/documents/generaldocuments/cms_053906.pdf. Accessed October 5, 2018.</Citation></Reference><Reference><Citation>Hindiyeh MY, et al. Development and validation of a real time quantitative reverse transcription-polymerase chain reaction (QRT-PCR) assay for investigation of wild poliovirus type 1-South Asian (SOAS) strain reintroduced into Israel, 2013 to 2014. Euro Surveill. 2014;19:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24576470</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman LM, et al. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS ONE. 2006;1:e69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1762338</ArticleId><ArticleId IdType="pubmed">17183700</ArticleId></ArticleIdList></Reference><Reference><Citation>Manor Y, et al. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl Environ Microbiol. 2007;73:5954&#x2013;5958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2074904</ArticleId><ArticleId IdType="pubmed">17660306</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran-Gilad J, et al. Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel. J Clin Virol. 2015;66:51&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">25866337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer BT, et al. Successes and shortcomings of polio eradication: A transmission modeling analysis. Am J Epidemiol. 2013;117:1236&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664334</ArticleId><ArticleId IdType="pubmed">23592542</ArticleId></ArticleIdList></Reference><Reference><Citation>Tien JH, Earn DJD. Multiple transmission pathways and disease dynamics in a waterborne pathogen model. Bull Math Biol. 2010;72:1506&#x2013;1533.</Citation><ArticleIdList><ArticleId IdType="pubmed">20143271</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg MC, Robertson SL, Tien JH. Identifiability and estimation of multiple transmission pathways in cholera and waterborne disease. J Theor Biol. 2013;324:84&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">23333764</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Spicknall IH, Koopman JS, Eisenberg JNS. Dynamics and control of infections transmitted from person to person through the environment. Am J Epidemiol. 2009;170:257&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">19474071</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer AF, et al. Dose-response relationships for environmentally mediated infectious disease transmission models. PLoS Comput Biol. 2017;13:e1005481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5400279</ArticleId><ArticleId IdType="pubmed">28388665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobelli C, DiStefano JJ. Parameter and structural identifiability concepts and ambiguities: A critical review and analysis. Am J Physiol. 1980;239:R7&#x2013;R24.</Citation><ArticleIdList><ArticleId IdType="pubmed">7396041</ArticleId></ArticleIdList></Reference><Reference><Citation>Raue A, et al. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics. 2009;25:1923&#x2013;1929.</Citation><ArticleIdList><ArticleId IdType="pubmed">19505944</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith EW, Kumar KSP. On the observability of nonlinear systems: I. J Math Anal Appl. 1971;35:135&#x2013;147.</Citation></Reference><Reference><Citation>Hwang M, Seinfeld JH. Observability of nonlinear systems. J Optim Theor Appl. 1972;10:67&#x2013;77.</Citation></Reference><Reference><Citation>Soetaert K, Petzoldt T, Setzer W. Package &#x2018;deSolve&#x2019;. 2017 Available at  https://cran.r-project.org/web/packages/deSolve/deSolve.pdf. Accessed October 5, 2018.</Citation></Reference><Reference><Citation>Luebeck G, Meza R. Bhat: General likelihood exploration. 2015 Available at  https://cran.r-project.org/web/packages/Bhat/Bhat.pdf. Accessed October 5, 2018.</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, et al. Characterizing poliovirus transmission and evolution: Insights from modeling experiences with wild and vaccine-related polioviruses. Risk Anal. 2013;33:703&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">23521018</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul J. World Health Organization Monograph Series No 26. World Health Organization; Geneva: 1955. Epidemiology of poliomyelitis; pp. 9&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">14374570</ArticleId></ArticleIdList></Reference><Reference><Citation>Krugman S, et al. Immunization with live attenuated poliovirus vaccine. Am J Dis Child. 1961;101:23&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">13754588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Earn DJ. Generality of the final size formula for an epidemic of a newly invading infectious disease. Bull Math Biol. 2006;68:679&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088645</ArticleId><ArticleId IdType="pubmed">16794950</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JC. A note on the derivation of epidemic final sizes. Bull Math Biol. 2012;74:2125&#x2013;2141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3506030</ArticleId><ArticleId IdType="pubmed">22829179</ArticleId></ArticleIdList></Reference><Reference><Citation>Famulare M, Selinger C, McCarthy KA, Eckhoff PA, Chabot-Couture G. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine. PLoS Biol. 2018;16:1&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5942853</ArticleId><ArticleId IdType="pubmed">29702638</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, et al. Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs. Risk Anal. 2013;33:606&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890644</ArticleId><ArticleId IdType="pubmed">23550968</ArticleId></ArticleIdList></Reference><Reference><Citation>Gog J. A status-based approach to multiple strain dynamics. Math Biol. 2002;44:169&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Asghar H, et al. Environmental surveillance for polioviruses in the global polio eradication initiative. J Infect Dis. 2014;210:S294&#x2013;S303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10578309</ArticleId><ArticleId IdType="pubmed">25316848</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson Muluh T, et al. Contribution of environmental surveillance toward interruption of poliovirus transmission in Nigeria, 2012-2015. J Infect Dis. 2016;213:131&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818559</ArticleId><ArticleId IdType="pubmed">26908747</ArticleId></ArticleIdList></Reference><Reference><Citation>Huda TMN, et al. Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. Am J Trop Med Hyg. 2013;89:130&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748469</ArticleId><ArticleId IdType="pubmed">23629931</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Cairncross S, Ensink JH. Water, sanitation, hygiene and enteric infections in children. Arch Dis Child. 2013;98:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3717778</ArticleId><ArticleId IdType="pubmed">23761692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassilak SGF, et al. Using acute flaccid paralysis surveillance as a platform for vaccine-preventable disease surveillance. J Infect Dis. 2017;216(Suppl 1):S293&#x2013;S298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853448</ArticleId><ArticleId IdType="pubmed">28838175</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L. &#x2018;What the hell is going on?&#x2019; Polio cases are vanishing in Pakistan, yet the virus won&#x2019;t go away. Science. 2018 doi: 10.1126/science.aas9789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aas9789</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowger TL, et al. The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan &#x2013; 2011&#x2013;2013. PLoS ONE. 2017;12:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5526532</ArticleId><ArticleId IdType="pubmed">28742803</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Papua New Guinea confirms poliovirus outbreak, launches response. 2018 Available at  www.wpro.who.int/papuanewguinea/mediacentre/releases/20180725/en/. Accessed October 5, 2018.</Citation></Reference><Reference><Citation>Gerloff N, et al. Diagnostic assay development for poliovirus eradication. J Clin Microbiol. 2018;56:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>Manukyan H, et al. Quantitative multiplex one-step RT-PCR assay for identification and quantitation of Sabin strains of poliovirus in clinical and environmental specimens. J Virol Methods. 2018;259:74&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">29920299</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez MH, Weitz JS. Distinguishing between indirect and direct modes of transmission using epidemiological time series. Am Nat. 2013;181:E43&#x2013;E52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348785</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg MC, Hayashi MAL. Determining identifiable parameter combinations using subset profiling. Math Biosci. 2014;256:116&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">25173434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionides EL, Nguyen D, Atchad&#xe9; Y, Stoev S, King AA. Inference for dynamic and latent variable models via iterated, perturbed Bayes maps. Proc Natl Acad Sci USA. 2015;112:719&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4311819</ArticleId><ArticleId IdType="pubmed">25568084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionides EL, Bhadra A, Atchad&#xe9; Y, King A. Iterated filtering. Ann Stat. 2011;39:1776&#x2013;1802.</Citation></Reference><Reference><Citation>Gamerman D, Lopes HF. Markov Chain Monte Carlo: Stochastic Simulation for Bayesian Inference. Chapman and Hall/CRC; London: 2006.</Citation></Reference><Reference><Citation>Liu J, et al. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: A multicentre study. Lancet Infect Dis. 2014;14:716&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pubmed">25022434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii S, et al. Microfluidic quantitative PCR for simultaneous quantification of multiple viruses in environmental water samples. Appl Environ Microbiol. 2014;80:7505&#x2013;7511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4249240</ArticleId><ArticleId IdType="pubmed">25261510</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwenhuijse DF, Koopmans MP. Metagenomic sequencing for surveillance of food- and waterborne viral diseases. Front Microbiol. 2017;8:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5309255</ArticleId><ArticleId IdType="pubmed">28261185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>